Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122512) titled 'A study to evaluate the efficacy and safety of weakly alkaline negatively potential single-molecule highly active water (AEMW) in improving comorbidities in patients undergoing chemotherapy for tumors' on April 14.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Dalian Medical University
Condition:
Hypertension, high blood sugar, high uric acid, fatigue, insomnia, constipation
Intervention:
Research group:Weakly alkaline negatively potential single-molecule highly active water intake
Recruitment Status: Not Recruiting
Phase: 4
Date of First En...